BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6452297)

  • 21. Topical erythromycin vs blank vehicle in a multiclinic acne study.
    Jones EL; Crumley AF
    Arch Dermatol; 1981 Sep; 117(9):551-3. PubMed ID: 6457568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of a topical preparation containing erythromycin in the treatment of acne.
    Puschmann M; Meyer-Rohn J
    Dermatologica; 1982 May; 164(5):343-9. PubMed ID: 6212272
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical erythromycin and zinc therapy for acne.
    Schachner L; Eaglstein W; Kittles C; Mertz P
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):253-60. PubMed ID: 2138176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of topical erythromycin 1.5 percent solution versus topical clindamycin phosphate 1.0 percent solution in the treatment of acne vulgaris.
    Thomas DR; Raimer S; Smith EB
    Cutis; 1982 Jun; 29(6):624-5, 628-32. PubMed ID: 6213379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharma Clinics. Drug of the month. Benzamycin, an up-date on topical treatment of acne].
    Piérard GE
    Rev Med Liege; 1997 Feb; 52(2):120-2. PubMed ID: 9173479
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical antibiotic monotherapy prescribing practices in acne vulgaris.
    Hoover WD; Davis SA; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2014 Apr; 25(2):97-9. PubMed ID: 24171409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythromycin "free base" -a nonsensitizing topical antibiotic for infected dermatoses and acne vulgaris.
    Fisher AA
    Cutis; 1977 Jul; 20(1):17, 26, 30 passim. PubMed ID: 141996
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of topical erythromycin on aerobic and anaerobic surface flora.
    Bernstein JE; Shalita AR
    Acta Derm Venereol; 1980; 60(6):537-9. PubMed ID: 6162344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythromycin and penetrating agents containing ointment in acne vulgaris therapy.
    Kasprowicz A; Krówczyński L; Jachowicz R; Białecka A
    Pol J Pharmacol Pharm; 1988; 40(5):465-9. PubMed ID: 2978177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle.
    Mills O; Thornsberry C; Cardin CW; Smiles KA; Leyden JJ
    Acta Derm Venereol; 2002; 82(4):260-5. PubMed ID: 12361129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical nadifloxacin 1% cream vs. topical erythromycin 4% gel in the treatment of mild to moderate acne.
    Tunca M; Akar A; Ozmen I; Erbil H
    Int J Dermatol; 2010 Dec; 49(12):1440-4. PubMed ID: 21091683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and bacteriological evaluation of nadifloxacin 1% cream in patients with acne vulgaris: a double-blind, phase III comparison study versus erythromycin 2% cream.
    Plewig G; Holland KT; Nenoff P
    Eur J Dermatol; 2006; 16(1):48-55. PubMed ID: 16436342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy of oral erythromycin versus oral tetracycline in the treatment of acne vulgaris. A double-blind study.
    Gammon WR; Meyer C; Lantis S; Shenefelt P; Reizner G; Cripps DJ
    J Am Acad Dermatol; 1986 Feb; 14(2 Pt 1):183-6. PubMed ID: 2936772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Topical treatment of acne vulgaris with erythromycin and benzoylperoxide (author's transl)].
    Gloor M; Pfahler E; Neumann W; Höffler U; Hoffmann M; Schmidt U
    Z Hautkr; 1982 Jun; 57(12):867-78. PubMed ID: 6214093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of systemic erythromycin stearate on the inflammatory lesions and skin surface fatty acids in acne vulgaris.
    Bleeker J; Hellgren L; Vincent J
    Dermatologica; 1981; 162(5):342-9. PubMed ID: 6454598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzoyl peroxide: enhancing antibiotic efficacy in acne management.
    Dutil M
    Skin Therapy Lett; 2010; 15(10):5-7. PubMed ID: 21076800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A new salt of erythromycin (A-137 or erythromycin lauryl sulfate) in the topical treatment of acne].
    Pérez López M; Moragas Viñas JM
    Med Cutan Ibero Lat Am; 1982; 10(3):151-8. PubMed ID: 6218350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion.
    Packman AM; Brown RH; Dunlap FE; Kraus SJ; Webster GF
    Int J Dermatol; 1996 Mar; 35(3):209-11. PubMed ID: 8655242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.